XML 88 R55.htm IDEA: XBRL DOCUMENT v3.22.0.1
Discontinued Operations - Summary of Financial Results for TS Biotechnology and EnviroFlight (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Jan. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Loss on release of cumulative foreign currency translation adjustment   $ 0 $ (26,957) $ 0
Income (loss) from discontinued operations   4,599 (66,748) (153,582)
TS Biotechnology Holdings, LLC | Discontinued Operations, Disposed of by Sale        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenue     1,294 12,307
Operating expenses     896 116,091
Operating income (loss)     398 (103,784)
Gain on sale of discontinued operations     633  
Loss on release of cumulative foreign currency translation adjustment $ (26,957)   (26,957)  
Other expense, net     (129) (272)
Income (loss) before income taxes     (26,055) (104,056)
Income tax (expense) benefit     (2) 3,005
Income (loss) from discontinued operations     (26,057) (101,051)
EnviroFlight Sale | Discontinued Operations, Disposed of by Sale        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenue     0 0
Operating expenses     0 10,794
Operating income (loss)     0 (10,794)
Gain on sale of discontinued operations     39  
Loss on release of cumulative foreign currency translation adjustment     0  
Other expense, net     0 0
Equity in net loss of affiliates     (38) (4,314)
Income (loss) before income taxes     1 (15,108)
Income tax (expense) benefit     0 0
Income (loss) from discontinued operations     1 (15,108)
TS Biotechnology Holdings, LLC and EnviroFlight, LLC | Discontinued Operations, Disposed of by Sale        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenue     1,294 12,307
Operating expenses     896 126,885
Operating income (loss)     398 (114,578)
Gain on sale of discontinued operations     672  
Loss on release of cumulative foreign currency translation adjustment     (26,957) 0
Other expense, net     (129) (272)
Equity in net loss of affiliates     (38) (4,314)
Income (loss) before income taxes     (26,054) (119,164)
Income tax (expense) benefit     (2) 3,005
Income (loss) from discontinued operations   $ 0 (26,056) (116,159)
Impairment charges       89,679
Related Parties, Aggregated | TS Biotechnology Holdings, LLC | Discontinued Operations, Disposed of by Sale        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenue     $ 436 $ 3,042